Who invested in Siolta Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$12Mraised across 1 round since 2024, from 1 source

Latest round: Series C, $12MMar 2024
Investors: 4

See who backed them

The rounds

Mar 2024
Series C$12M
Source recorded

Founders and team

From Siolta Therapeutics's own website: 2 founders, 5 on the team.

Nikole Kimes PhDFounder and Chief Executive Officer

Susan Lynch PhDFounder and Board of Directors

Ricardo Valladares PhDChief Scientific Officer
Alison Vrbanac PhDSenior Scientist - Bioinformatics Lead
Andrew H. Kim PhDSenior Scientist - Bioinformatics
Kevin Foley PhDSenior Scientist
Neeraja Vajrala PhDDirector of Microbiology

AdvisersClifford SamuelJohn C. MartinMatthew Meyer

Everyone who backed them

Khosla VenturesVC firm1round

Global Brain CorporationVC firm1round

Seventure PartnersVC firm1round

National Institute of Allergy and Infectious DiseasesInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Siolta Therapeutics

Who invested in Siolta Therapeutics?

Siolta Therapeutics's investors include Khosla Ventures, Global Brain Corporation, Seventure Partners and National Institute of Allergy and Infectious Diseases.

How much has Siolta Therapeutics raised?

Siolta Therapeutics has raised $12M across 1 round since 2024.

When did Siolta Therapeutics last raise?

Siolta Therapeutics's most recent round was a Series C of $12M in Mar 2024.

What was Siolta Therapeutics's biggest round?

Its most recent round, $12M in Mar 2024, is also its largest on record.

Who backed Siolta Therapeutics first?

Siolta Therapeutics's first round on record, in Mar 2024, was backed by Khosla Ventures, Global Brain Corporation and Seventure Partners and 1 others.